Luis R. Martinez Department of Microbiology and Immunology Albert Einstein College of Medicine Biography Publications Institution JoVE Articles Luis R. Martinez has not added a biography. If you are Luis R. Martinez and would like to personalize this page please email our Author Liaison for assistance. Publications Nitric Oxide-Releasing Nanoparticles Accelerate Wound Healing by Promoting Fibroblast Migration and Collagen Deposition The American Journal of Pathology. Feb, 2012 | Pubmed ID: 22306734 Effects of Microplusin, a Copper-chelating Antimicrobial Peptide, Against Cryptococcus Neoformans FEMS Microbiology Letters. Nov, 2011 | Pubmed ID: 22092765 Chronological Aging is Associated with Biophysical and Chemical Changes in the Capsule of Cryptococcus Neoformans Infection and Immunity. Dec, 2011 | Pubmed ID: 21968999 Improved Antimicrobial Efficacy with Nitric Oxide Releasing Nanoparticle Generated S-nitrosoglutathione Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. Nov, 2011 | Pubmed ID: 21946032 Susceptibility of Gram-positive and -negative Bacteria to Novel Nitric Oxide-releasing Nanoparticle Technology Virulence. May-Jun, 2011 | Pubmed ID: 21577055 Candida Parapsilosis Fat Storage-inducing Transmembrane (FIT) Protein 2 Regulates Lipid Droplet Formation and Impacts Virulence Microbes and Infection / Institut Pasteur. Jul, 2011 | Pubmed ID: 21396481 Mycobacteria Release Active Membrane Vesicles That Modulate Immune Responses in a TLR2-dependent Manner in Mice The Journal of Clinical Investigation. Apr, 2011 | Pubmed ID: 21364279 Novel Therapies for Treatment of Multi-drug Resistant Acinetobacter Baumannii Skin Infections Virulence. Mar-Apr, 2011 | Pubmed ID: 21321482 Fungal Biofilms: Relevance in the Setting of Human Disease Current Fungal Infection Reports. Dec, 2010 | Pubmed ID: 21660222 The Use of Nitric Oxide Releasing Nanoparticles As a Treatment Against Acinetobacter Baumannii in Wound Infections Virulence. Mar-Apr, 2010 | Pubmed ID: 21178416 Monoclonal Antibodies Against Peptidorhamnomannans of Scedosporium Apiospermum Enhance the Pathogenicity of the Fungus PLoS Neglected Tropical Diseases. 2010 | Pubmed ID: 20976055 Demonstration of Antibiofilm and Antifungal Efficacy of Chitosan Against Candidal Biofilms, Using an in Vivo Central Venous Catheter Model The Journal of Infectious Diseases. May, 2010 | Pubmed ID: 20331379 Augmented Production of Panton-Valentine Leukocidin Toxin in Methicillin-resistant and Methicillin-susceptible Staphylococcus Aureus is Associated with Worse Outcome in a Murine Skin Infection Model The Journal of Infectious Diseases. Jan, 2010 | Pubmed ID: 19929693 The Use of Chitosan to Damage Cryptococcus Neoformans Biofilms Biomaterials. Feb, 2010 | Pubmed ID: 19819009 Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus Aureus Abscesses in a Murine Model of Infection PloS One. 2009 | Pubmed ID: 19915659 Methamphetamine Enhances Histoplasmosis by Immunosuppression of the Host The Journal of Infectious Diseases. Jul, 2009 | Pubmed ID: 19473099 Antimicrobial and Healing Efficacy of Sustained Release Nitric Oxide Nanoparticles Against Staphylococcus Aureus Skin Infection The Journal of Investigative Dermatology. Oct, 2009 | Pubmed ID: 19387479 Characterization of Phenotypic Switching in Cryptococcus Neoformans Biofilms Mycopathologia. Oct, 2008 | Pubmed ID: 18568421 Voriconazole Inhibits Melanization in Cryptococcus Neoformans Antimicrobial Agents and Chemotherapy. Dec, 2007 | Pubmed ID: 17923488 Caspofungin Reduces the Incidence of Fungal Contamination in Cell Culture Mycopathologia. Dec, 2007 | Pubmed ID: 17899440 Cryptococcus Neoformans Biofilm Formation Depends on Surface Support and Carbon Source and Reduces Fungal Cell Susceptibility to Heat, Cold, and UV Light Applied and Environmental Microbiology. Jul, 2007 | Pubmed ID: 17513597 Cryptococcus Neoformans Cells in Biofilms Are Less Susceptible Than Planktonic Cells to Antimicrobial Molecules Produced by the Innate Immune System Infection and Immunity. Nov, 2006 | Pubmed ID: 17057089 Specific Antibody to Cryptococcus Neoformans Glucurunoxylomannan Antagonizes Antifungal Drug Action Against Cryptococcal Biofilms in Vitro The Journal of Infectious Diseases. Jul, 2006 | Pubmed ID: 16779734 Susceptibility of Cryptococcus Neoformans Biofilms to Antifungal Agents in Vitro Antimicrobial Agents and Chemotherapy. Mar, 2006 | Pubmed ID: 16495265 Specific Antibody Can Prevent Fungal Biofilm Formation and This Effect Correlates with Protective Efficacy Infection and Immunity. Oct, 2005 | Pubmed ID: 16177306 Antibody to Cryptococcus Neoformans Glucuronoxylomannan Inhibits the Release of Capsular Antigen Infection and Immunity. Jun, 2004 | Pubmed ID: 15155683 Пассивный Администрации моноклональных антител против H. capsulatum И другие грибным патогенам Allan J. Guimarães1, Luis R. Martinez1, Joshua D. Nosanchuk1 1Department of Microbiology and Immunology, Albert Einstein College of Medicine JoVE 2532 면역학 및 감염병학
Пассивный Администрации моноклональных антител против H. capsulatum И другие грибным патогенам Allan J. Guimarães1, Luis R. Martinez1, Joshua D. Nosanchuk1 1Department of Microbiology and Immunology, Albert Einstein College of Medicine JoVE 2532 면역학 및 감염병학